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1À10 Two well-studied example regulatory systems are the tetracycline (tet) and luminescence (lux) operons. The tetracycline repressor protein, TetR, and numerous TetR derivatives afford a remarkably robust function of inducible repression and derepression of gene expression. Thus, they have been employed in numerous synthetic biology and bioengineering applications. 11À14 Switching gene expression on and off by TetR and its derivatives simply depends on the presence or absence of the antibiotic tetracycline (Tc). The lux operon's transcription activator protein, LuxR, is another attractive controllable molecular component for engineering applications. When induced, it activates gene overexpression by recruiting transcriptional machinery to the promoter. In addition, a number of variant activators have been identified that upregulate transcription over a range of strengths with varied dependence on inducer molecules.
15À18
Herein, we present two novel synthetic molecular devices that inducibly upregulate bacterial gene expression. We have designed, built, and characterized these devices using a unique methodology that is based on both computational and experimental efforts. Both devices are composed of an inducible DNA-binding domain and a transcription activation domain. In particular, TetR and the reverse-TetR (rTetR) derivative were chosen for the inducible domains while the transactivating domain of LuxR was incorporated for transcription upregulation.
19À22 TetR protein and its derivative, rTetR, dissociate from and bind to the tetO operator sequence in response to Tc, respectively.
19À21
This behavior made them attractive candidates for controlling our devices. In addition, LuxRΔN(2À162) (LuxRΔN) is the C-terminal, constitutive transactivating domain of the full length LuxR activator. Strong, constitutive transcription activation is achieved with this variant lacking the N-terminal residues 2À162 of the full protein. 22 These specific protein components were selected as they have been thoroughly studied and well characterized. Specifically, the protein:DNA-operator crystal structures for both domains as well as the kinetic parameters that govern their protein:protein and protein:DNA interactions were available in the literature.
We designed, constructed, and characterized the two new devices using an original workflow that integrates experimental synthetic biology, molecular modeling, and stochastic reaction kinetic simulations. This methodology may be directly implemented for the development of other biological devices and larger regulatory networks. The devices we present here, prokaryotic-TetOn and prokaryotic-TetOff (proTeOn and proTeOff), function in an Tcdependent manner: the proTeOn synthetic protein (PROTEON) activates gene expression in the presence of Tc, and the proTeOff synthetic protein (PROTEOFF) activates expression in the absence of Tc. Orders of magnitude higher expression levels are observed in the activating states compared to the basal expression levels of both systems. With these new devices, there is now a dial of activated expression to complement those of basal and repressed gene expression.
While the proTeOn and proTeOff systems are functionally unique, their designs are conceptually inspired by the widely used TetOn and TetOff systems, which function in eukaryotic systems.
23, 24 Gossen and co-workers fused the TetR protein to a mammalian transactivating domain, building molecular devices that activate eukaryotic gene expression in a Tc-dependent manner. To our knowledge, there were no prokaryotic transcription factors homologous to TetOn or TetOff prior to the construction of proTeOn and proTeOff. Additionally, our kind of engineering approach to synthetic biology, using molecular dynamic simulations to guide system design and stochastic simulations to enhance system characterization, has not been previously reported in the literature.
The proposed behaviors of proTeOn and proTeOff are illustrated in Figure 1 . As shown, anhydrotetracycline (aTc), a Tc derivative, was used as the inducer in our experiments. For proTeOn, in the absence of aTc, the inducible DNA binding domain, rTetR, does not bind the tetO operator and the PROTEON protein does not upregulate the target gene, green fluorescence protein (gfp). 21 Upon activation with aTc, rTetR binds the inducer, undergoes a conformational change and binds tetO. 21 This binding brings LuxRΔNnear its operator site, allowing it to bind luxbox and upregulate gfp transcription through RNA polymerase (RNApol) recruitment to the promoter. 25À27 For proTeOff, in the absence of aTc, its inducible DNA binding domain, TetR, binds tetO. 2, 20, 28, 29 This binding brings LuxRΔNclose to its operator site, permitting it to bind luxbox, and upregulate gfp transcription.
25À27 After the addition of aTc, TetR binds the small molecule, undergoes a conformational change and releases tetO. 2, 20, 28, 29 Upon dissociation of TetR:tetO, the LuxRΔN:luxbox interaction is destabilized and transcription upregulation is terminated.
To achieve these phenotypes, we first used molecular modeling to design the geometry of the synthetic transactivator/ promoter pairs of each system. The important feature of proTeOn and proTeOff on which we focused was the optimized interaction between the inducible synthetic transactivator protein that upregulates gene expression and its complementary synthetic promoter. Next, we built and characterized both systems experimentally. Last, implementing stochastic simulations, we explored the system dynamics and quantified unknown kinetic parameters of key interactions. The workflow is detailed in the Methods section. In the Results and Discussion section, we begin by presenting elements of the model-driven design of the devices.
ProTeOn and proTeOff can be applied to robustly manage prokaryotic gene expression. Variant systems and more complex inducible gene regulatory networks can also be designed and constructed using this workflow and the proTeOn and proTeOff systems as a foundation.
' RESULTS AND DISCUSSION proTeOn and proTeOff Designs. For proTeOn and proTeOff to perform efficiently, both protein domains (TetR/rTetR and LuxRΔN) must readily bind their operator sequences upon induction, LuxRΔNmust recruit RNApol to the promoter, and then RNApol must bind to the promoter and begin transcription. Numerous length and space requirements are associated with each of these steps, and we systematically accommodated each of them by designing the devices prior to construction. To satisfy the above geometric constraints, we built molecular models of each system using MOE 30 and NAMD. 31 With the chosen protein components and DNA operator sites as starting points, the entire DNA promoter sequence and the linker amino acid sequence were designed in tandem.
First, the synthetic promoter for both systems was designed, and the optimized sequence is annotated in Figure 2a . The major aim of the promoter design was to minimize the distance between the two DNA-bound protein domains while maintaining favorable binding between the domains and their operators. The interactions between RNApol and the specific residues of the promoter to which it binds (the UP element and the À10 region) had to be accommodated as well. To meet these aims, the operator sites were integrated into the promoter such that the two domains bound along the same face of the DNA (Figure 2b , side view) while maintaining a minimum distance between the two operator sites. The final design was scrutinized to ensure that neither DNA-bound protein domain was encroaching the residues of the UP element or À10 region as this would inhibit efficient RNApol recruitment.
Next, we optimized the peptide linker required to connect the two DNA-bound protein domains (TetR/rTetR's C-terminus to LuxRΔN's N-terminus). We did this by assuming it resembles a polymer in good solution and choosing a length that would minimize the entropic elastic tension effects. The optimal linker length was determined to be 150 Å, and the final sequence is the product of 5 repeats of a 9-amino acid subunit, ARTQYSESM. The individual subunits are connected by single glycine residues, and this 49-amino acid peptide is flanked by 3 glycine residues on each side. These were chosen to ensure linker flexibility and promote correct protein domain folding. The final optimized proTeOn system, meeting all geometric requirements, is illustrated in Figure 2b .
Characterization of proTeOn and proTetOff Behavior. To investigate the behavior of both systems and determine the optimal conditions and applications of each device, we performed two sets of experiments. First, cells expressing the transactivators were induced with a range of aTc concentrations. Second, cultures were primed with these aTc amounts prior to transactivator expression. In both experiments we monitored the resulting differential expression of the target gene, gfp, over time. Induction experiments were repeated for all inducer concentrations and time points. The reported trends were observed across the replicates.
proTeOn. Upon administration of aTc, proTeOn upregulates target genes by 1 h post-treatment and achieves 15-fold upregulation through long times. With a low (10 ng/mL) aTc concentration, proTeOn can achieve steady state expression of targets 10-fold over untreated cultures just 5 h post-treatment. With a high (200 ng/mL) aTc concentration, target gene expression can reach steady state by 10 h post-treatment at levels 15-fold over untreated cultures. These behaviors are displayed as both expression means and population distributions in Figure 3a . Basal GFP expression levels are observed from the synthetic promoter in the absence of aTc. There is no repressed state for the proTeOn system as presented here.
PROTEON expressed in the presence of aTc gives target gene upregulation within 2 h. Steady state upregulation is achieved by 5 h after the transactivator's initial expression, with GFP expression 10-fold over uninduced controls. PROTEON is thus rapidly transcribed, translated, and folded and becomes functional when under the control of a free, nonrepressed, promoter. This is shown in Figure 3b . The mean behaviors taken across biological replicates are discussed in the Supporting Information and shown in Supporting Figure 3 .
Applications of proTeOn would be appropriate in systems when quick bursts or long-term gene upregulation is desired. Such behavior is governed by rTetR's responses to induction with aTc. This control is achievable with inducer levels as low as 10 ng/mL aTc. aTc concentrations outside of this range, or scaled throughout an experiment, may be useful depending upon the desired level of activation. Notably, long-term target gene upregulation increases with aTc up to 200 ng/mL. Thus, inducing with a range of aTc concentrations, proTeOn can be tuned to robustly upregulate gene expression for both acute and long time scales.
proTeOff. In the absence of aTc, proTeOff activates target gene expression. Upon administration of aTc, upregulation can be reduced by half just 1 h post-treatment. Steady state target gene expression is only one-half and one-fifth that of untreated samples with low and high aTc concentrations, respectively. This is observed as early as 5 h and remains through long times. While activation by proTeOff is significantly reduced with low aTc concentrations, a subset of activator proteins still appears to bind the promoter and upregulate transcription. With GFP levels at only one-fifth of the untreated controls, we consider the low GFP expression observed with 200 ng/mL aTc to be the synthetic promoter's basal expression level. These low basal expression levels are observed through long times. These behaviors are presented also as expression means and population distributions in Figure 4a . Please note that there is also no repressed state for the proTeOff system as presented here.
PROTEOFF expressed in the absence of aTc leads to target gene upregulation within 1 h and maintains it through long times. PROTEOFF is therefore quickly transcribed, translated, and folded and is functional when under the control of a free, nonrepressed promoter. In the presence of low and high aTc concentrations, the device activity is maintained at less than onefifth of untreated cultures 1 h after the PROTEOFF's initial . proTeOff system phenotype analysis by flow cytometry. Mean GFP expression and expression distribution were analyzed by flow cytometry 1, 2, 5, 10, and 20 h post-treatment for both experimental set-ups as described. Induction experiments were repeated for all inducer concentrations and time points, and the reported trends were observed across replicates. (a) With 0 ng/mL, proTeOff upregulates GFP expression. With 10 and 200 ng/mL aTc, expression is reduced to half that of untreated samples by 1 h. Steady state expression is reached by 5 h and maintained through 20 h post-treatment. Minimum expression is one-half and one-fifth that of untreated samples with low and high aTc, respectively. (b) PROTEOFF was expressed in cells precultured with 0, 10, and 200 ng/mL aTc. In 0 ng/mL aTc, proTeOff activity is observed (via GFP upregulation) 1 h after PROTEOFF expression is induced. In low and high aTc, reduced proTeOff activity is observed across all times and steady state activity is achieved by 5 h after initial PROTEOFF expression. High aTc levels maintain the reduced device activity and thus basal GFP expression. Low concentrations permit GFP levels to rise to onethird that of untreated cultures. Both of these behaviors are observed through 20 h.
transactivator's initial expression, where it remains through long times. This elevation is due to a subset of free PROTEOFFs binding to the promoter and recruiting RNApol. These data are shown in Figure 4b . The mean behaviors taken across biological replicates are discussed in the Supporting Information and shown in Supporting Figure 3 . proTeOff can be applied to upregulate gene expression for both short and long times. Continuous long-term upregulation as well as upregulation with intermittent periods of low expression can be achieved. These behaviors are governed by TetR's response to aTc. aTc concentrations as low as 10 ng/mL effectively achieve periods of low expression. Target gene expression drops with increasing aTc concentrations of 10À200 ng/mL. aTc concentrations outside of this range or scaled throughout an experiment may also achieve a desired phenotype. Thus, proTeOff can be tuned to upregulate gene expression for short, long-continuous, and long-intermittent time scales using a range of aTc concentrations.
Characterization of proTeOn and proTeOff kinetics. In addition to experimentally testing proTeOn and proTeOff, we have assessed the kinetics of both systems by conducting stochastic simulations. This was done to characterize the systems at a finer resolution than can be achieved in the lab alone. We aimed to quantify the strength of the interactions between the device components by developing a stochastic model that captures the time profiles of measured GFP probability distributions. We modeled the transcription, translation, regulatory, and degradation events with stochastic kinetics. We built the models and conducted the simulations as described before 32À41 and discussed in the Supporting Information. Stochastic model parameters that did not exist in the literature were fit to match the untreated experimental phenotypes (0 ng/mL) and the behaviors upon induction with both low and high aTc concentrations (10 and 200 ng/mL). The mean GFP expression is captured by the model for both proTeOn and proTeOff at short times post-aTc induction (1 and 5 h) as well as at steady state (10 h), as shown in Figure 5 . Overall, the mean GFP levels achieved by the simulation trajectories agree well with the experimental observations. A discrepancy is observed between the simulation and experimental results at 5 h with 200 ng/mL aTc. This may be attributed to high aTc levels retarding cellular processes, such as protein overexpression.
42 By 10 h, this effect is no longer experimentally significant, and a good match is therefore observed between theoretical and experimental results. Due to their stochastic nature, the models can also capture the GFP distributions observed experimentally at short and long times. The GFP distributions at 10 h for proTeOn and 1 h for proTeOff, when 0, 10, and 200 ng/mL aTc are administered, are presented in Figure 6 . For both systems, and across all aTc concentrations, the distributions generated in silico match those observed in vivo.
The protein:DNA binding strengths in the proTeOn and proTeOff systems are characterized by four kinetic parameters. These values, extracted from the models, are given in Table 1 . Binding of aTc to PROTEON increases the affinity of the latter for the promoter 10,000-fold. Binding of PROTEOFF to aTc leads to a decrease in the affinity of PROTEOFF to tetO by 10 8 times. Both PROTEON and PROTEOFF enhance gfp expression significantly when bound to tetO by recruiting RNApol to the promoter. In our simulations, this is realized by increasing the binding strength of RNApol to DNA. Conforming to the simulation results, binding of PROTEON to tetO increases the binding strength of RNApol to DNA approximately 22 times, whereas binding of PROTEOFF to tetO increases the binding strength around 14 times.
Conclusions. The engineered proTeOn and proTeOff systems can all be applied to tightly control gene expression with aTc in prokaryotes. Incorporating appropriate tags in the target genes' transcripts may render proTeOn and proTeOff powerful tools for cytosolic, membrane-associated, and secreted protein overexpression.
More broadly, however, the workflow presented here can be implemented in the design, construction, and testing of a library of variant devices and regulatory networks. Such devices include those that respond to sugars, proteins, amino acids, metabolites, toxins, and other small molecules. With these, one may efficiently engineer gene expression responses as applications demand. As the collection of well characterized synthetic devices grows, we may also be able to combine them, along with naturally occurring parts, into larger gene regulatory networks to achieve more complex desired phenotypes. Feedback loops, feedforward loops, and AND and OR logic gates are a few possible networks. These devices and networks may then be used either as tools for controlling the expression of a single gene or as interoperable parts of larger regulatory networks that control multiple genes independently. The current proTeOn and proTeOff devices and the kinetic and structural details that have been identified for each are a firm stepping stone from which this work can expand. Using our workflow, integrating experimental synthetic biology, molecular modeling, and stochastic reaction kinetic simulations, the required effort and expense that scale with system complexity will also be reduced. Molecular devices that can tunably regulate the expression of a single or a handful of genes in response to sugar, protein, amino acid, metabolite, toxin, and other small molecule levels may provide synthetic biology research and the bioengineering industry the tools they need for efficient, diverse gene expression control. 2,19À21,28,29 LuxRΔN(2À162) (LuxRΔN) is the DNA-binding activator at the C-terminus of both synthetic proteins. 22 LuxRΔNis the C-terminal domain of the full length LuxR transactivator. It lacks N-terminal residues 2À162 of the full length LuxR and possesses strong constitutive transactivator activity. 22 In both systems, the two domains are connected by a 150 Å, 55 amino acid peptide linker (its design is discussed below). and LuxRΔN, 25, 26, 29 RNApolymerase (RNApol) binding sequences (the UP element and À10 region), 27 transcription and translation start sites, an mRNA stabilizing sequence, and a ribosomal binding site 43 are included. These sequences are annotated in Figure 2a . Green fluorescence protein mutant 3 (GFP) is the reporter molecule used to monitor the systems' behavior and is under the control of the synthetic promoter. 44 A second synthetic promoter, containing the RBS of the lux promoter and lacking the mRNA stability sequence was also tested. This promoter provided gfp transcript increase upon induction. However, a parallel increase in GFP protein was not observed.
Molecular Modeling. We designed the proTeOn and proTeOff systems using molecular modeling with MOE 30 and with NAMD. 31 We built models of the systems utilizing the known structure of the inducible DNA binding domain (rTetR or TetR) bound to the tetO operator (PDB code 1QPI) 19 and the transcription activator domain (LuxRΔN) bound to the luxbox (PDB code 1H0M). 45 The linker size was determined by assuming the scaling of polymer's end-to-end vector distance in a good solvent. 46 The specific sequence was then determined to minimize proteolysis in bacteria. We thus designed a 55-amino acid linker peptide, which is expected to be linear, flexible, and hydrophilic. 47 System Construction. Both synthetic activator genes were synthesized by GENEART using standard molecular biology techniques, cloned into the expression vector pT7-FLAG1 (p1118 Sigma), at KPN1 restriction sites, using Top10 Escherichia coli (E. coli) cells (C404010 Invitrogen). The final constructs are illustrated in Supporting Figure 1a . The synthetic promoter and gfp 44 were synthesized by GENEART, on pMK, a pUC19 derived expression vector that is compatible in E. coli, high copy, and kanamycin-resistant. This construct is illustrated in Supporting Figure 1b . proTeOn and proTeOff are contained on these two plasmids and were transformed into chemically competent BL21(DE3)-T1 E. coli cells (B2935 Sigma) by heat shock for characterization.
Gene Expression Control by Tetracycline in Bacterial
Cultures. BL21(DE3)-T1 cells containing the proTeOn and proTeOff systems were cultured in selective LB media, at 30°C to facilitate temperature-sensitive folding of LuxRΔN, agitating at 200 rpm. Cultures were maintained in midlog growth. We completed initial experiments to first confirm the solubility and stability of PROTEON and PROTEOFF and then to establish promoter specific gene regulation by aTc (rather than a general soluble protein upregulation).
Basal, low, medium, and high levels of the synthetic activators were maintained with 0, 0.25, 0.75, and 1 mM IPTG, respectively. Each system was induced over a range of aTc concentrations, 1, 10, and 200 ng/mL. The total soluble protein was isolated from cultures with CelLyticB reagent (B7435 Sigma), separated by size on a 10% polyacrylamide gel, and transferred to PVDF membrane. PROTEON was detected by primary mouse monoclonal anti-FLAG M2 antibody (F3165 Sigma), GFP by mouse monoclonal anti-GFP antibody [LGB-1] (ab291 Abcam), and loading control RNApol by mouse monoclonal anti-RNApol sigma 70 antibody [2G10] (ab12088). Biotinylated, polyclonal sheep antimouse secondary antibody, VECTASTAIN ABC kit (PK-4002 Vector Laboratories), and Amersham ECL Western blotting detection reagent (RPN 2109) were used to complete the specific detection of each protein. Relative quantification of each protein was performed using ImageJ software, publicly available at http://rsb.info. nih.gov, taking the ratio of protein of interest to RNApol density. PROTEON and PROTEOFF are soluble and stable at high intracellular concentrations, and gene regulation by aTc is specific to genes under the control of the synthetic promoter. This is discussed in Supporting Information and illustrated in Supporting Figure 2 .
We characterized each system maintaining PROTEON and PROTE-OFF expression with 0.75 mM IPTG and controlling the activity of each device with 0, 10, and 200 ng/mL aTc. Two sets of experiments were performed. In experiment setup A, PROTEON and PROTEOFF production was induced overnight with 0.75 mM IPTG and 0 ng/mL aTc; at t = 0 h cultures were treated with 0, 10, and 200 ng/mL aTc. In experiment setup B cultures were treated overnight with 0, 10, and 200 ng/mL aTc and 0 mM IPTG; at t = 0 PROTEON and PROTEOFF expression was induced with 0.75 mM IPTG. Experiments A investigated the proTeOn and proTeOff system dynamics upon induction with aTc, whereas experiments B provided insight on the PROTEON and PROTEOFF protein production and maturation dynamics.
IPTG and aTc levels were maintained in the cultures at all t > 0 h. Induction experiments were repeated for all inducer concentrations and time points, and reported trends were observed across replicates.
Cell samples were collected for analysis by flow cytometry at t = 1, 2, 5, 10, and 20 h, fixed with 4% paraformaldehyde for 30 min at RT, washed with 1x phosphate buffered saline (PBS), and stored in 1x PBS at 4°C. Individual cells' GFP expression was measured by flow cytometry using a FACScalibur (BD Biosciences). A total of 100,000 cells was investigated per sample with excitation at λ ex = 488 nm and subsequent fluorescence detection at λ em = 530 ( 30 nm. The cytometry data was collected using CellQuest (BD Biosciences) and analyzed using FlowJo (Tree Star) software. Each sample's healthy cell population was selected by first removing erroneous events (due to electronic noise) that fell below a minimum emission at λ em = 530 ( 30 nm and then removing events that fell outside of the characteristic side-scatter and forwardscatter range for single E. coli cells. The differential GFP expression of the selected cells was analyzed and compared across samples.
Mean Gene Expression Data Analysis. All cytometry data was collected as described above. Prior to evaluating data across replicates, all GFP expression values were normalized to their corresponding (same system and time point) 0 ng/mL aTc samples. Basal expression (achieved with 0 ng/mL) from the proTeOn system is denoted with a value of 1. In contrast, maximal expression (also achieved with 0 ng/mL) from the proTeOff system is denoted with a value of 1. This basis is consistent for both experimental setups and through all times. Normalized GFP expression averages and standard errors were then calculated for replicates.
Stochastic modeling. We built computer models of proTeOn and proTeOff to further characterize the experimental behavior of each system. A hybrid stochastic-discrete and stochastic-continuous algorithm called Hy3S was used. 38, 39 Hy3S couples chemical Langevin equations with discrete kinetic Monte Carlo, modeling a system's behavior at the resolution of biomolecular interactions in individual cells. Characteristics of numerous natural and synthetic biological systems have previously been described using this approach. 32, 37, 38, 40, 41 The simulations were carried out under a number of key assumptions and parameters that are discussed in the Supporting Information.
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